Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Beckman Coulter; Covance; Van Andel Research Institute, Aushon BioSystems; Galapagos, Roche; CLC Bio, Riken; Biocius; SBS, ALA

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Beckman Coulter said in a filing with the US Securities and Exchange Commission today that the US Food and Drug Administration is requiring a prospective clinical study to gain 510(k) clearance for its troponin test for use on all of its automated immunoassay instruments. Last month, the firm said that it would remove its AccuTnI troponin test kits from use with its UniCel DxI immunoassay system as of May 31 due to a positive bias identified months earlier.


Covance this week said that it has launched a new unit, called the Discovery & Translational Services group, which integrates the firm's discovery services, antibody products and immunology services, Biomarker Center of Excellence, and Genomics Laboratory. The clinical research organization said that the group will leverage its equity stakes in Caprion Proteomics and Rules-Based Medicine.


The Van Andel Research Institute will use Aushon BioSystems' 2470 Arrayer technology in its Laboratory of Cancer Immunodiagnostics for the development of protein analysis methods used to identify and study protein abnormalities in the blood of cancer patients.


Galapagos this week said that it has expanded a research alliance with Roche to discover and develop new therapies for chronic obstructive pulmonary disease. The firms initially agreed to collaborate in January 2010, and Galapagos received €6 million ($7.4 million) from Roche. The Belgian firm, which is using its target discovery platform under the deal, could receive an additional €150 million in payments if certain milestones are met.


CLC Bio said this week that Riken Omics Science Center will use the firm's high-throughput sequence analysis infrastructure to manage and analyze large quantities of genomics data.


Biocius has opened a European office near Geneva to support sales and service for its RapidFire high-throughput mass spectrometry platform.


Members of the Society for Biomolecular Sciences and the Association for Laboratory Automation have authorized the merger of the two groups, with more than 95 percent of members voting in favor, they said this week. The merged organization will be known as the Society for Laboratory Automation and Screening.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.